Hair-Thinning.co.uk is operated by BMJ Trading Ltd, incorporated in the United Kingdom.

Nourkrin Trials

Nourkrin has been clinically proven to improve hair count and decrease thinning hair.

The many users of Nourkrin who have completed a course of supplementation have witnessed the initial slowing of the hair loss process, followed by the period of thickening and regrowth.

"supplementing with Nourkrin tablets demonstrated a significant improvement"
During a course of treatment over six months, a double-blind placebo study involving 60 individuals suffering from hair loss, showed that 77% of subjects benefited from Nourkrin. These results took the form of increased hair growth and improved thickness.

Compared with the placebo group, the individuals supplementing with Nourkrin tablets demonstrated a significant improvement in hair growth.

Further, over the course of 12 months, the Nourkrin subjects showed continued betterment of their hair loss condition; proving that the period of supplementation is a key factor in the success of the treatment.


Key findings from previous studies and surveys include:
  • Significant decrease of thinning hair reported in over three quarters of two hundred male trial participants.
  • Ninety percent of female subjects in a Swedish Nourkrin trial reported a 50% improvement.
  • 83% of Nourkrin users polled by Nourkrin indicated that they felt their hair loss was now under control.
The numerous scientific studies conducted demonstrate conclusively that Nourkrin is an effective treatment for alopecia. Hair loss and thinning is first markedly reduced, before thickening and regrowth occurs.





Registered in the United Kingdom. Company 05539358. VAT GB895749938.